Free Trial

Markets Limited As COVID Headlines Dominate

SNAPSHOT

Below gives key levels of markets in the second half of the Asia-Pac session:

  • Nikkei 225 up 24.37 points at 23628.65
  • ASX 200 down 5.849 points at 6189.9
  • Shanghai Comp. down 18.021 points at 3341.729
  • JGB 10-Yr future up 5 ticks at 151.99, yield down 0bp at 0.030%
  • Aussie 10-Yr future up 1.0 tick at 99.160, yield down 0.9bp at 0.839%
  • U.S. 10-Yr future -0-01 at 139-05+, yield up 0.17bp at 0.729%
  • WTI crude down $0.12 at $40.08, Gold up $4.88 at $1896.42
  • USD/JPY down 5 pips at Y105.43
  • U.S. PAUSES ELI LILLY'S TRIAL OF COVID ANTIBODY TREATMENT OVER SAFETY CONCERNS (CNBC)
  • UK GOVERNMENT SCIENTIFIC ADVISERS URGE TWO-WEEK LOCKDOWN (FT)
  • NETHERLANDS IMPOSES 'PARTIAL' LOCKDOWN TO CONTAIN SPREAD OF CORONAVIRUS (FRANCE 24)
  • DECEMBER NEXT STEP ON BOE'S NEGATIVE RATE PATH (MNI)
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com
MNI London Bureau | +44 0203-865-3809 | anthony.barton@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.